Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $5.0250 (-4.29%) ($5.0250 - $5.0250) on Thu. Sep. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.21% (three month average) | RSI | 40 | Latest Price | $5.0250(-4.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 1.3% a day on average for past five trading days. | Weekly Trend | IOVA declines -5.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBUY(85%) IPO(94%) SLV(93%) SIL(63%) SKYY(12%) | Factors Impacting IOVA price | IOVA will decline at least -2.605% in a week (0% probabilities). UUP(-86%) FXI(-69%) USO(-67%) UNG(-62%) TBT(-53%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.605% (StdDev 5.21%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-8.76(-274.33%) | Resistance Level | $5.75 | 5 Day Moving Average | $5.37(-6.42%) | 10 Day Moving Average | $5.47(-8.14%) | 20 Day Moving Average | $5.75(-12.61%) | To recent high | -42.4% | To recent low | 8.2% | Market Cap | $736m | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |